Xtl Biopharmaceuticals Ltd 's ROA from the fourth quarter of 2023 to the fourth quarter of 2022 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics

What is Xtl Biopharmaceuticals Ltd 's ROA in the fourth quarter of 2023?

However, within the Healthcare sector 334 other companies had a higher return on assets. While return on assets, the total ranking has deteriorated compared to the third quarter of 2023 from to 4071.

What is ROA?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Assets ROA▼

None ▼

Return on Assets ROA▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Assets	(Dec 31 2023) IV. Quarter	0 III. Quarter	0 II. Quarter	0 I. Quarter	(Dec 31 2022) IV. Quarter
Y / Y Total Assets Change	215.99 %	186.93 %	-38.55 %	-42.04 %	-49.65 %
Y / Y Net Income Change	-	-	-	-	-
Net Income (TTM) in million	0	0	0	0	0
Return On Assets (TTM)	0 %	0 %	0 %	-9.63 %	-8.38 %
XTLB's Total Ranking	# 4071	#	#	#	# 5003
Total Assets (TTM) in million	8	7	3	2	2
Seq. Total Assets Change	10.13 %	148.08 %	15.66 %	0 %	0 %
Seq. Net Income Change	-	-	-	-	-

XTLB's 5 Years Annual ROA >> Back to XTLB Management Effectiveness >> Compare XTLB ROA to its Competitors

Return On Assets Company Ranking
Within:	No.
Industry	# 116
Sector	# 335
Overall	# 3988

Return On Assets Statistics
High	Average	Low
42.33 %	-8.55 %	-45.43 %
(Dec 31 2018)		(Dec 31 2020)

Financial Statements
Xtl Biopharmaceuticals Ltd 's Assets	$ 8 million	XTLB's Balance sheet
Xtl Biopharmaceuticals Ltd 's Income	$ 0 million	Quarterly XTLB's Income Statement
XTLB's Income by Division		See XTLB's Income by Division

Annual Return On Assets	(Dec 31 2023) FY 2024	(Dec 31 2023) FY 2023	(Dec 31 2022) FY 2022	(Dec 31 2021) FY 2021	(Dec 31 2020) FY 2020
Y / Y Total Assets Change	173.2 %	-38.55 %	-34.75 %	-24.7 %	-5.79 %
Total Assets in million	8	3	5	7	9
Y / Y Net Income Change	-	-	-	-	-
Net Income in million	-1	-2	-1	0	-3
Annual Return On Assets	-13.4 %	-63.51 %	-29.52 %	6.22 %	-31.78 %

XTLB's 5 Years Annual ROA >> Back to XTLB Management Effectiveness >> Compare XTLB ROA to its Competitors

More Return On Assets Ratios
XTLB's' Return on Assets at Yahoo Finance
Major Pharmaceutical Preparations Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
XTLB's Roa Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for XTLB's Competitors
Subscribers only: Roa for Xtl Biopharmaceuticals Ltd 's Suppliers
Subscribers only: Return On Assets for XTLB's Customers

You may also want to know
XTLB's Roi	XTLB's Inventory Turnover Ratio	XTLB's Growth Rates	XTLB's Dividend Comparisons
	XTLB's Profitability Ratios	XTLB's Asset Turnover Ratio	XTLB's Dividend Growth
XTLB's Roe	XTLB's Valuation Ratios	XTLB's Financial Strength Ratios	XTLB's Dividend Payout Ratio

Companies with similar Return On Assets at Dec 31 2023, within Healthcare Sector

ROA

Date modified: 2024-05-02T15:34:24+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.